FNCH Insider Trading
Insider Ownership Percentage: 44.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Finch Therapeutics Group Insider Trading History Chart
This chart shows the insider buying and selling history at Finch Therapeutics Group by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Finch Therapeutics Group Share Price & Price History
Current Price: $13.50
Price Change: ▼ Price Decrease of -0.65 (-4.59%)
As of 04/4/2025 04:55 PM ET
Finch Therapeutics Group Insider Trading History
Finch Therapeutics Group Institutional Trading History
Data available starting January 2016
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.
Read More on Finch Therapeutics Group
Today's Range
Now: $13.50
52 Week Range
Now: $13.50
Volume
1,689 shs
Average Volume
2,165 shs
Market Capitalization
$21.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.25
Who are the company insiders with the largest holdings of Finch Therapeutics Group?